Pulmonary artery compliance in different forms of pulmonary hypertension

被引:10
作者
McCormick, Amber [1 ]
Krishnan, Amita [1 ]
Badesch, David [2 ]
Benza, Raymond L. [3 ]
Bull, Todd M. [2 ]
De Marco, Teresa [4 ]
Feldman, Jeremy [5 ]
Hemnes, Anna R. [6 ]
Hirsch, Russel [7 ]
Horn, Evelyn [8 ]
Kennedy, Jaime [9 ]
Mathai, Stephen C. [10 ]
McConnell, Wesley [11 ]
Pugliese, Steven C. [12 ]
Sager, Jeffrey S. [13 ]
Shlobin, Oksana A. [14 ]
Simon, Marc A. [4 ]
Lammi, Matthew R. [1 ]
机构
[1] Louisiana State Univ, Comprehens Pulm Hypertens Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA
[2] Univ Colorado Anschutz Med Campus, Div Pulm Sci & Crit Care Med, Denver, CO USA
[3] Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Div Cardiovasc Med, Columbus, OH USA
[4] Univ Calif San Francisco, Div Cardiol, San Francisco, CA USA
[5] Arizona Pulm Specialists, Phoenix, AZ USA
[6] Vanderbilt Univ, Allergy Pulm & Crit Care Med, Nashville, TN USA
[7] Cincinnati Childrens Hosp Med Ctr, Heart Inst, Cincinnati, OH USA
[8] Weill Cornell Med Coll, Div Cardiol, New York, NY USA
[9] Inova Heart & Vasc Inst, Falls Church, VA USA
[10] Johns Hopkins Univ, Pulm & Crit Care Med, Baltimore, MD USA
[11] Kentuckiana Pulm Associates, Louisville, KY USA
[12] Univ Penn, Pulm Allergy & Crit Care, Philadelphia, PA USA
[13] Cottage Pulm Hypertens Ctr, Santa Barbara, CA USA
[14] Inova Fairfax Hosp, Adv Lung Disesae & Transplant Program, Falls Church, VA USA
关键词
Pulmonary Arterial Hypertension; Pulmonary Embolism; RIGHT-VENTRICULAR AFTERLOAD; SYSTEMIC-SCLEROSIS; VASCULAR-RESISTANCE; TIME CONSTANT; CAPACITANCE; MANAGEMENT; SURVIVAL; THERAPY;
D O I
10.1136/heartjnl-2022-321760
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective Pulmonary artery compliance (PAC), estimated as stroke volume (SV) divided by pulmonary artery pulse pressure (PP), may be a predictor of survival in pulmonary arterial hypertension (PAH). Resistance- compliance (RC) time, the product of PAC and pulmonary vascular resistance, is reported to be a physiological constant. We investigated if differences in PAC and RC time exist between pulmonary hypertension (PH) subgroups and examined whether PAC is an independent predictor of transplant- free survival in PAH.Methods This was a retrospective analysis of adult PAH (n=532) and chronic thromboembolic PH (CTEPH, n=84) patients enrolled in the US Pulmonary Hypertension Association Registry from 2015 to 2019. PAC and RC time were compared between PH subgroups (connective tissue disease-PAH (CTD-PAH), idiopathic/heritable-PAH (i/h- PAH), drug/toxin- PAH (d/t-PAH)). Cox proportional hazards models were constructed for transplant- free survival, adjusting for REVEAL 2.0 risk score.Results There were no differences in estimated PAC between PAH subgroups, nor between PAH and CTEPH. RC time was shorter in CTEPH compared with PAH (median 0.55 (IQR 0.45-0.64) vs 0.62 (0.52-0.73) s, p < 0.0001). RC time was shortest in CTD- PAH when compared with i/h- PAH and d/t- PAH ((0.59 +/- 0.18) vs (0.65 +/- 0.20) vs (0.73 +/- 0.25) s, p=0.0001). PAC was associated with transplant- free survival (HR 0.72, 95% CI 0.55 to 0.94, p=0.02) but was not an independent predictor of outcome after adjustment for REVEAL 2.0 score.Conclusion PAC was similar between PH groups and was not an independent predictor of transplant- free survival in PAH. RC time was different between PH subgroups, challenging RC time constancy.
引用
收藏
页码:1098 / 1105
页数:8
相关论文
共 50 条
  • [31] Acute Effects of Vardenafil on Pulmonary Artery Responsiveness in Pulmonary Hypertension
    Karasu-Minareci, Edibe
    Ozbudak, Irem Hicran
    Ozbilim, Gulay
    Sadan, Gulay
    SCIENTIFIC WORLD JOURNAL, 2012,
  • [32] Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound
    Lau, Edmund M. T.
    Iyer, Nithin
    Ilsar, Rahn
    Bailey, Brian P.
    Adams, Mark R.
    Celermajer, David S.
    PLOS ONE, 2012, 7 (03):
  • [33] Prevalence and predictors of chronic thromboembolic pulmonary hypertension following severe forms of acute pulmonary embolism
    Pargana, Joana
    Cale, Rita
    Martinho, Mariana
    Santos, Joao
    Lourenco, Candida
    Pereira, Jose Alberto Castro
    Araujo, Patricia
    Morgado, Joao
    Pereira, Ernesto
    Judas, Tiago
    Alegria, Sofia
    Ferreira, Filipa
    Delerue, Francisca
    Pereira, Helder
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2023, 42 (12) : 947 - 958
  • [34] Pulmonary Hypertension in Women
    Franco, Veronica
    Ryan, John J.
    McLaughlin, Vallerie V.
    HEART FAILURE CLINICS, 2019, 15 (01) : 137 - +
  • [35] Pulmonary Arterial Hypertension
    Centeno, Mae M.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2011, 23 (04) : 645 - +
  • [36] Imaging of Pulmonary Hypertension
    Francois, Christopher J.
    Schiebler, Mark L.
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2016, 54 (06) : 1133 - +
  • [37] Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension
    Minai, Omar A.
    ANNALS OF THORACIC MEDICINE, 2014, 9 (05) : 92 - 97
  • [38] Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
    Bonner, Nicola
    Abetz, Linda
    Meunier, Juliette
    Sikirica, Mirko
    Mathai, Stephen C.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [39] Pulmonary hypertension due to a pulmonary artery leiomyosarcoma: A case report
    Adeli, Hassan
    Nemati, Bardia
    Jandaghi, Mahboubeh
    Riahi, Mohammad Mahdi
    Salarvand, Fatemeh
    ARYA ATHEROSCLEROSIS, 2014, 10 (02) : 133 - 136
  • [40] Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension
    Hoette, Susana
    Figueiredo, Claudia
    Dias, Bruno
    Alves-, Jose Leonidas, Jr.
    Gavilanes, Francisca
    Prada, Luis Felipe
    Jasinowodolinski, Dany
    Kato Morinaga, Luciana Tamie
    Jardim, Carlos
    Cesar Fernandes, Caio Julio
    Souza, Rogerio
    BMC PULMONARY MEDICINE, 2015, 15